Latest Europe News

Provaris Energy has achieved a major breakthrough with a term sheet for green hydrogen supply to Uniper, marking Europe's first large-scale regional hydrogen marine transport project. Concurrently, the company is advancing innovative CO2 tank designs in partnership with Yinson, positioning itself at the forefront of energy transition infrastructure.

Talga Group has achieved critical milestones with environmental permits and a 25-year mining concession for its Nunasvaara South graphite mine, alongside securing a €70 million EU Innovation Fund grant for its Luleå Anode Refinery, positioning it at the forefront of Europe's battery materials supply chain.

Genesis Resources Limited has completed its acquisition of full ownership of the Silgen joint venture controlling the Plavica project in North Macedonia, while preparing for follow-up drilling in its Australian tenements amid ongoing environmental studies.

Lykos Metals Limited reports significant high-grade mineral findings at its Sinjakovo Project and extends its Jezero exploration permit, alongside key board appointments and cost restructuring.

Ionic Rare Earths reports strong progress on its Belfast rare earth oxide recycling facility, backed by a robust feasibility study and UK government grant applications, alongside strategic developments in Brazil and Uganda.

Wide Open Agriculture reports a 50% reduction in overheads alongside the development of a novel lupin-based tofu product, positioning itself for growth in the global plant protein market.

Opthea Limited reports steady progress in its Phase 3 trials for sozinibercept, a novel treatment for wet AMD, supported by a strong cash position and a recent R&D tax incentive.

Elementos Limited reports significant progress in its Oropesa and Cleveland tin projects, positioning itself as a key supplier in Europe amid tightening global tin markets.

Peak Rare Earths Limited has made significant strides in developing its Ngualla Rare Earth Project, completing an $8.5 million capital raise and progressing key negotiations with Shenghe Resources. Community initiatives and asset sales further underpin its growth strategy.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Po Valley Energy Limited reports a robust December 2024 quarter marked by rising gas production, strong revenue growth, and significant progress in exploration and development across its Italian assets.